Lynch & Associates Medtronic PLC Transaction History
Lynch & Associates
- $467 Million
- Q3 2024
A detailed history of Lynch & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Lynch & Associates holds 7,324 shares of MDT stock, worth $597,638. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,324
Previous 6,324
15.81%
Holding current value
$597,638
Previous $497,000
32.6%
% of portfolio
0.14%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding MDT
# of Institutions
2,288Shares Held
1.02BCall Options Held
8.05MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA123MShares$10.1 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.13 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.7MShares$4.96 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA32.6MShares$2.66 Billion0.63% of portfolio
-
Jpmorgan Chase & CO New York, NY30.7MShares$2.51 Billion0.23% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $108B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...